Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Pruritus – Pipeline Review, H1 2017 Market Research Report

Monday, March 20, 2017 2:12
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Ethocle Reports has published its latest Market Research Report on Pruritus – Pipeline Review, H1 2017.  Pruritus (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Pruritus and features dormant and discontinued projects. Browse market data tables and figures.

        

                                                                                                                Published On: 15-Mar-2017 | Pages: 117

Summary

Pharmaceutical and Healthcare disease pipeline guide Pruritus – Pipeline Review, H1 2017, provides an overview of the Pruritus (Dermatology) pipeline landscape.

Pruritus, or itch, is defined as an unpleasant sensation that provokes the desire to scratch. Pruritus is caused by cancer, cancer treatments, infection, dry skin and reaction to a drug. Symptoms include redness, bumps, spots or blisters, dry, cracked skin and leathery or scaly texture to the skin. Risk factors include heat, allergic, asthma, hay fever, hives and eczema. Treatment includes corticosteroids, antihistamines and antidepressants.

Capture.PNG     d.PNG     dd.PNG

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Pruritus – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Pruritus (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Pruritus (Dermatology).

- The pipeline guide reviews pipeline therapeutics for Pruritus (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Pruritus (Dermatology) therapeutics and enlists all their major and minor projects.

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Pruritus (Dermatology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

Table of Contents

Introduction

Global Markets Direct Report Coverage

Pruritus – Overview

Pipeline Overview

Pruritus – Therapeutics Assessment

Assessment by Target

Pruritus – Companies Involved in Therapeutics Development

Asana BioSciences LLC

Cara Therapeutics Inc

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories
 

Featured

 

Top Global

 

Top Alternative

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.